tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine

C114H132F15N23S5 — CID 158209374

IUPACtris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine
SMILESCN1CCN(Cc2ccc(CN3CCC(Nc4ncnc5sc(CC(F)(F)F)cc45)CC3)cc2)CC1.Cc1ccc(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)cc1.Cc1ccc(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)cc1.Cc1ccc(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)cc1.FC(F)(F)Cc1cc2c(NC3CCN(Cc4ccc(N5CCCCC5)cc4)CC3)ncnc2s1
InChIInChI=1S/C26H33F3N6S.C25H30F3N5S.3C21H23F3N4S/c1-33-10-12-35(13-11-33)17-20-4-2-19(3-5-20)16-34-8-6-21(7-9-34)32-24-23-14-22(15-26(27,28)29)36-25(23)31-18-30-24;26-25(27,28)15-21-14-22-23(29-17-30-24(22)34-21)31-19-8-12-32(13-9-19)16-18-4-6-20(7-5-18)33-10-2-1-3-11-33;3*1-14-2-4-15(5-3-14)12-28-8-6-16(7-9-28)27-19-18-10-17(11-21(22,23)24)29-20(18)26-13-25-19/h2-5,14,18,21H,6-13,15-17H2,1H3,(H,30,31,32);4-7,14,17,19H,1-3,8-13,15-16H2,(H,29,30,31);3*2-5,10,13,16H,6-9,11-12H2,1H3,(H,25,26,27)
InChIKeyGBWPNCGYAKGXGI-UHFFFAOYSA-N
MW2269.78 g/mol
LogP26.03
Rot. Bonds28

About tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine

tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine (PubChem CID 158209374) has the molecular formula C114H132F15N23S5 and a molecular weight of 2269.78 g/mol. Its IUPAC name is tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine.

Molecular Properties

Compound Nametris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine
PubChem CID158209374
Molecular FormulaC114H132F15N23S5
Molecular Weight2269.78 g/mol
Exact Mass2267.94
IUPAC Nametris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine
SMILESCN1CCN(Cc2ccc(CN3CCC(Nc4ncnc5sc(CC(F)(F)F)cc45)CC3)cc2)CC1.Cc1ccc(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)cc1.Cc1ccc(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)cc1.Cc1ccc(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)cc1.FC(F)(F)Cc1cc2c(NC3CCN(Cc4ccc(N5CCCCC5)cc4)CC3)ncnc2s1
InChIInChI=1S/C26H33F3N6S.C25H30F3N5S.3C21H23F3N4S/c1-33-10-12-35(13-11-33)17-20-4-2-19(3-5-20)16-34-8-6-21(7-9-34)32-24-23-14-22(15-26(27,28)29)36-25(23)31-18-30-24;26-25(27,28)15-21-14-22-23(29-17-30-24(22)34-21)31-19-8-12-32(13-9-19)16-18-4-6-20(7-5-18)33-10-2-1-3-11-33;3*1-14-2-4-15(5-3-14)12-28-8-6-16(7-9-28)27-19-18-10-17(11-21(22,23)24)29-20(18)26-13-25-19/h2-5,14,18,21H,6-13,15-17H2,1H3,(H,30,31,32);4-7,14,17,19H,1-3,8-13,15-16H2,(H,29,30,31);3*2-5,10,13,16H,6-9,11-12H2,1H3,(H,25,26,27)
InChIKeyGBWPNCGYAKGXGI-UHFFFAOYSA-N
XLogP26.03
TPSA214.97 Ų
H-Bond Donors5
H-Bond Acceptors28
Rotatable Bonds28
Heavy Atoms157
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002269.78
LogP ≤ 526.03
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_D(198)', 'substructure': 'N/A'}, {'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}

Analyze tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine?
The IUPAC name of tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine (CID 158209374) is tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine.
What is the SMILES notation for tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine?
The canonical SMILES for tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine is CN1CCN(Cc2ccc(CN3CCC(Nc4ncnc5sc(CC(F)(F)F)cc45)CC3)cc2)CC1.Cc1ccc(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)cc1.Cc1ccc(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)cc1.Cc1ccc(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)cc1.FC(F)(F)Cc1cc2c(NC3CCN(Cc4ccc(N5CCCCC5)cc4)CC3)ncnc2s1.
What is the InChIKey of tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine?
The InChIKey is GBWPNCGYAKGXGI-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H33F3N6S.C25H30F3N5S.3C21H23F3N4S/c1-33-10-12-35(13-11-33)17-20-4-2-19(3-5-20)16-34-8-6-21(7-9-34)32-24-23-14-22(15-26(27,28)29)36-25(23)31-18-30-24;26-25(27,28)15-21-14-22-23(29-17-30-24(22)34-21)31-19-8-12-32(13-9-19)16-18-4-6-20(7-5-18)33-10-2-1-3-11-33;3*1-14-2-4-15(5-3-14)12-28-8-6-16(7-9-28)27-19-18-10-17(11-21(22,23)24)29-20(18)26-13-25-19/h2-5,14,18,21H,6-13,15-17H2,1H3,(H,30,31,32);4-7,14,17,19H,1-3,8-13,15-16H2,(H,29,30,31);3*2-5,10,13,16H,6-9,11-12H2,1H3,(H,25,26,27).
What are the key properties of tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine?
tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine has a molecular weight of 2269.78 g/mol, XLogP of 26.03, 28 rotatable bonds, 5 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for tris(N-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine);N-[1-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine;N-[1-[(4-piperidin-1-ylphenyl)methyl]piperidin-4-yl]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-amine is sourced from PubChem (CID 158209374), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).